Adalimumab/certolizumab pegol/infliximabPsoriasis and psoriasiform eruptions: 14 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1660卷 / 1期

关键词：

D O I：

10.1007/s40278-017-32981-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：16 / 16

相关论文

共 50 条

[21] Adalimumab/efalizumab/infliximabPsoriasis: 5 case reports
Reactions Weekly, 2008, 1210 (1) : 5 - 5
[22] Adalimumab/etanercept/infliximabPsoriasis: 4 case reports
Reactions Weekly, 2008, 1209 (1) : 6 - 6
[23] Adalimumab/etanercept/infliximabPsoriasis: 6 case reports
Reactions Weekly, 2013, 1438 (1) : 5 - 5
[24] Adalimumab/etanercept/infliximabPsoriasis: 25 case reports
Reactions Weekly, 2009, 1241 (1) : 6 - 6
[25] Adalimumab/certolizumab pegol/infliximabDisseminated tuberculosis: case report
Reactions Weekly, 2017, 1682 (1) : 20 - 20
[26] Adalimumab/etanercept/infliximabPsoriasis (first report with adalimumab): 5 case reports
Reactions Weekly, 2005, 1075 (1) : 6 - 7
[27] Adalimumab/infliximabPsoriasis and psoriasisiform exanthema: 6 case reports
Reactions Weekly, 2008, 1184 (1) : 6 - 6
[28] Adalimumab/Certolizumab-pegol/MethotrexateMiliary histoplasmosis: case report
Reactions Weekly, 2024, 2028 (1) : 23 - 23
[29] Adalimumab/certolizumab pegol/ciclosporin/infliximabMycobacterium marinum: case report
Reactions Weekly, 2016, 1631 (1) : 17 - 17
[30] InfliximabPsoriasis and psoriasiform skin lesions in paediatric patients: 18 case reports
Reactions Weekly, 2013, 1454 (1) : 25 - 25

← 1 2 3 4 5 →